| Systematic versus on-demand early palliative care: results from a multicentre, randomised clinical trial M Maltoni, E Scarpi, M Dall'Agata, V Zagonel, R Bertè, D Ferrari, ... European Journal of Cancer 65, 61-68, 2016 | 176 | 2016 |
| Systematic versus on-demand early palliative care: a randomised clinical trial assessing quality of care and treatment aggressiveness near the end of life M Maltoni, E Scarpi, M Dall’Agata, S Schiavon, C Biasini, C Codecà, ... European Journal of Cancer 69, 110-118, 2016 | 158 | 2016 |
| Early Palliative Care Italian Study Group (EPCISG). Systematic versus on-demand early palliative care: results from a multicentre, randomised clinical trial M Maltoni, E Scarpi, M Dall’Agata, V Zagonel, R Bertè, D Ferrari, ... Eur J Cancer 65, 61-8, 2016 | 25 | 2016 |
| A proposal of a “ready to use” COVID-19 control strategy in an oncology ward: utopia or reality? D Dalu, S Rota, MS Cona, AM Brambilla, S Ferrario, A Gambaro, L Meroni, ... Critical Reviews in Oncology/Hematology 157, 103168, 2021 | 13 | 2021 |
| The emotional impact of the COVID-19 outbreak on cancer outpatients and their caregivers: results of a survey conducted in the midst of the Italian pandemic MS Cona, E Rulli, D Dalu, F Galli, S Rota, S Ferrario, N Tosca, A Gambaro, ... Supportive Care in Cancer 30 (2), 1115-1125, 2022 | 9 | 2022 |
| ABCB1 c. 3435C> T polymorphism is associated with platinum toxicity: a preliminary study B De Troia, D Dalu, V Filipazzi, L Isabella, N Tosca, S Ferrario, ... Cancer Chemotherapy and Pharmacology 83, 803-808, 2019 | 9 | 2019 |
| A targeted approach to genetic counseling in breast cancer patients: the experience of an Italian local project N La Verde, F Corsi, A Moretti, B Peissel, D Dalu, S Girelli, C Fasola, ... Tumori Journal 102 (1), 45-50, 2016 | 8 | 2016 |
| Position paper of the Italian association of medical oncology on health disparities among transgender and gender-diverse people: the Assisi recommendations AG Leone, R Casolino, D Trapani, R Miceli, M Massagrande, F Morano, ... EClinicalMedicine 65, 2023 | 7 | 2023 |
| Cancer care in transgender and gender-diverse persons: results from two national surveys among providers and health service users by the Italian Association of Medical Oncology AG Leone, R Miceli, D Trapani, M Massagrande, F Morano, S Marsoni, ... ESMO open 8 (3), 101578, 2023 | 5 | 2023 |
| Immunogenicity of two doses of BNT162b2 and mRNA‐1273 vaccines for solid cancer patients on treatment with or without a previous SARS‐CoV‐2 infection N La Verde, A Riva, MS Cona, A Gabrieli, M Cattaneo, C Fasola, G Lipari, ... International journal of cancer 152 (4), 661-671, 2023 | 5 | 2023 |
| Pegylated liposomal doxorubicin as first line treatment in aids-related Kaposi’s sarcoma: A real-life study D Dalu, C Fasola, L Ammoni, D De Francesco, MS Cona, S Rota, ... Journal of Chemotherapy 33 (5), 342-347, 2021 | 5 | 2021 |
| Host-related factors in the interplay among inflammation, immunity and dormancy in breast Cancer recurrence and prognosis: An overview for clinicians L Ruggieri, A Moretti, R Berardi, MS Cona, D Dalu, C Villa, D Chizzoniti, ... International Journal of Molecular Sciences 24 (5), 4974, 2023 | 4 | 2023 |
| Clinical efficacy of the first two doses of anti‐SARS‐CoV‐2 mRNA vaccines in solid cancer patients MS Cona, A Riva, D Dalu, A Gabrieli, C Fasola, G Lipari, G Pozza, E Rulli, ... Cancer Medicine 12 (12), 12967-12974, 2023 | 2 | 2023 |
| Single nucleotide polymorphisms to predict taxanes toxicities and effectiveness in cancer patients S Demurtas, N La Verde, S Rota, G Casazza, C Montrasio, S Cheli, ... The Pharmacogenomics Journal 21 (4), 491-497, 2021 | 2 | 2021 |
| Antibody response to three‐dose anti‐SARS‐CoV‐2 mRNA‐vaccination in treated solid cancer patients D Dalu, M Tarkowski, L Ruggieri, MS Cona, A Gabrieli, D De Francesco, ... International Journal of Cancer 154 (8), 1371-1376, 2024 | 1 | 2024 |
| 1570P The emotional impact of COVID-19 outbreak on cancer out-patients and their caregivers: Impressions from the heart of the Italian pandemic MS Cona, D Dalu, S Ferrario, N Tosca, AR Gambaro, V Filipazzi, S Rota, ... Annals of Oncology 31, S956-S957, 2020 | 1 | 2020 |
| Non-Hodgkin lymphoma in HIV-positive patients treated with antiretroviral therapy and chemotherapy: A single institution retrospective study D Dalu, C Fasola, D De Francesco, G Bombonati, L Ammoni, ... Annals of Oncology 30, v436, 2019 | 1 | 2019 |
| IGEV AN EFFECTIVE SALVAGE AND MOBILIZING REGIMEN IN REFRACTORY OR RELAPSED HODGKIN LYMPHOMA (HL): THE ISTITUTO NAZIONALE TUMORI EXPERIENCE D Dalu, S Viviani, M Di Nicola, C Carlo-Stella, AM Gianni HAEMATOLOGICA 95, S31-S31, 2010 | 1 | 2010 |
| TARC Is Useful as Additional Prognostic Factor for Hodgkin's Lymphoma Outcome. S Viviani, A Mazzocchi, V Bonfante, R Miceli, D Dalu, M Galbiati, ... Blood 114 (22), 1557, 2009 | 1 | 2009 |
| OC-52 Overcoming HPV vaccination barriers in target populations: the VACCINAMILANO experience P Raimondo, D Dalu, E Caruso, C Fusetti, C Fasola, D Calzavara, ... Sexually Transmitted Infections 100 (Suppl 1), A52-A53, 2024 | | 2024 |
